BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su Y, Wang Z, Ye J, Feng T, Wang F, Chi H, Zhou Z, Hu Q, Liu H, Cheng X, Shi H, Teng J, Yang C, Sun Y. Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease. Front Med (Lausanne) 2019;6:266. [PMID: 31824953 DOI: 10.3389/fmed.2019.00266] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Cota-Arce JM, Cota J, De León-Nava MA, Hernández-Cáceres A, Moncayo-Salazar LI, Valle-Alvarado F, Cordero-Moreno VL, Bonfil-Solis KL, Bichara-Figueroa JE, Hernández-Hernández J, Villela L. Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review. Semin Arthritis Rheum 2021:S0049-0172(21)00161-X. [PMID: 34493394 DOI: 10.1016/j.semarthrit.2021.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum 2021;51:858-74. [PMID: 34175791 DOI: 10.1016/j.semarthrit.2021.06.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
3 Tian R, Chen X, Yang C, Teng J, Qu H, Liu HL. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis. Front Immunol 2021;12:654811. [PMID: 33868298 DOI: 10.3389/fimmu.2021.654811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sun Y, Wang F, Zhou Z, Teng J, Su Y, Chi H, Wang Z, Hu Q, Jia J, Liu T, Liu H, Cheng X, Shi H, Tan Y, Yang C, Ye J. Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still's Disease. Front Immunol 2020;11:2112. [PMID: 33013889 DOI: 10.3389/fimmu.2020.02112] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]